Citadel Advisors Portfolio holdings
Citadel Advisors, founded in 1990 by Kenneth C. Griffin as Citadel LLC and headquartered in Chicago, Illinois, is one of the world’s most prominent hedge funds, managing tens of billions in assets through sophisticated quantitative trading strategies. The firm excels in market-making and high-frequency trading across asset classes like equities, fixed income, options, and commodities, leveraging cutting-edge technology and data analysis to generate returns. Citadel operates two main arms: its hedge fund business, which serves institutional and high-net-worth investors, and Citadel Securities, a leading market maker that facilitates a significant portion of U.S. equity and options trades. Known for its secretive, high-performance culture, Citadel has grown into a financial titan under Griffin’s leadership, influencing global markets with its scale and innovation.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Amazon
AMZN
|
+$615M |
| 2 |
Uber
UBER
|
+$551M |
| 3 |
Expedia Group
EXPE
|
+$523M |
| 4 |
PayPal
PYPL
|
+$452M |
| 5 |
Eaton
ETN
|
+$408M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
CELG
Celgene Corp
CELG
|
+$681M |
| 2 |
RTN
Raytheon Company
RTN
|
+$543M |
| 3 |
Alphabet (Google) Class A
GOOGL
|
+$537M |
| 4 |
Charter Communications
CHTR
|
+$472M |
| 5 |
SPDR Gold Trust
GLD
|
+$464M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 5.14% |
| 2 | Financials | 4.52% |
| 3 | Industrials | 4.17% |
| 4 | Healthcare | 3.91% |
| 5 | Consumer Discretionary | 3.68% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
8151
Ovid Therapeutics
OVID
$491M
| $158K | ﹤0.01% |
+38,088
| New | +$120K |
|
8152
SEACOR Marine Holdings
SMHI
$258M
| $158K | ﹤0.01% |
+11,459
| New | +$149K |
|
|
AXU
8153
DELISTED
Alexco Resource Corp
AXU
| $157K | ﹤0.01% |
67,618
-34,885
| -34% | -$64.3K |
|
|
VER
8154
CALL
DELISTED
VEREIT, Inc.
VER
| $157K | ﹤0.01% |
3,400
-3,660
| -52% | -$175K |
|
8155
PUT
Calumet Specialty Products
CLMT
$3.44B
| $156K | ﹤0.01% |
42,800
-77,900
| -65% | -$269K |
|
8156
Verastem
VSTM
$610M
| $156K | ﹤0.01% |
9,681
+260
| +3% | +$3.74K |
|
|
CRCM
8157
PUT
DELISTED
CARE.COM, INC.
CRCM
| $156K | ﹤0.01% |
10,400
-42,600
| -80% | -$511K |
|
8158
PUT
Kura Oncology
KURA
$850M
| $155K | ﹤0.01% |
+11,300
| New | +$167K |
|
8159
PUT
Novavax
NVAX
$1.31B
| $155K | ﹤0.01% |
38,900
+23,700
| +156% | +$103K |
|
8160
Rambus
RMBS
$11B
| $155K | ﹤0.01% |
11,244
-474,357
| -98% | -$6.37M |
|
8161
PUT
Syndax Pharmaceuticals
SNDX
$1.82B
| $155K | ﹤0.01% |
17,700
-65,800
| -79% | -$483K |
|
|
MAAS
8162
Maase Inc
MAAS
$8.29B
| $155K | ﹤0.01% |
+414
| New | +$137K |
|
|
ADMS
8163
DELISTED
Adamas Pharmaceuticals
ADMS
| $155K | ﹤0.01% |
41,154
+8,553
| +26% | +$40.9K |
|
|
CYOU
8164
PUT
DELISTED
Changyou.com Limited American Depositary Share
CYOU
| $155K | ﹤0.01% |
15,800
-2,400
| -13% | -$23.1K |
|
|
CHU
8165
DELISTED
China Unicom (HONG KONG) Limited
CHU
| $155K | ﹤0.01% |
16,561
+2,793
| +20% | +$26.8K |
|
|
ONCY
8166
Oncolytics Biotech
ONCY
$95.8M
| $154K | ﹤0.01% |
32,465
+15,549
| +92% | +$17.6K |
|
|
ACHN
8167
PUT
DELISTED
Achillion Pharmaceuticals
ACHN
| $154K | ﹤0.01% |
25,600
-4,200
| -14% | -$24.3K |
|
|
LUNA
8168
DELISTED
Luna Innovations Incorporated
LUNA
| $154K | ﹤0.01% |
+21,036
| New | +$139K |
|
8169
Arbutus Biopharma
ABUS
$915M
| $153K | ﹤0.01% |
+54,993
| New | +$89K |
|
8170
ProShares Ultra Euro
ULE
$4.43M
| $153K | ﹤0.01% |
+11,092
| New | +$150K |
|
|
CBAY
8171
CALL
DELISTED
Cymabay Therapeutics
CBAY
| $153K | ﹤0.01% |
78,300
-52,600
| -40% | -$198K |
|
|
AUTL
8172
Autolus Therapeutics
AUTL
$562M
| $152K | ﹤0.01% |
+11,541
| New | +$151K |
|
|
NGD
8173
PUT
DELISTED
New Gold Inc
NGD
| $152K | ﹤0.01% |
172,900
-127,100
| -42% | -$115K |
|
8174
Rayonier Advanced Materials
RYAM
$610M
| $152K | ﹤0.01% |
39,519
-31,976
| -45% | -$131K |
|
|
UNIT
8175
Uniti Group
UNIT
$2.32B
| $152K | ﹤0.01% |
18,475
-259,190
| -93% | -$1.88M |
|
Similar funds
Citadel Advisors's Q4 2019 Portfolio in Review
As of Q4 2019, Citadel Advisors held 10,299 positions worth $230B, up 8.7% from $212B the previous quarter. Its ten largest holdings account for 23% of the portfolio.
Citadel Advisors withdrew a net $8.18B in Q4 2019, closing 1,266 positions and reducing 4,117 holdings. Its most notable exit was Celgene Corp, an estimated $681M position sold in full.
By sector, the portfolio is most concentrated in Technology at 5.1% of assets, down from 5.3% a quarter earlier, followed by Financials and Industrials.
Against the trend, Citadel Advisors opened a new position in Interxion Holding N.V. worth $83.9M.
- Citadel Advisors's largest Q4 2019 buy was Interxion Holding N.V.: 1,000,931 shares worth $83.9M.
- Citadel Advisors added most to Amazon in Q4 2019, an estimated $615M increase.
- Citadel Advisors's biggest Q4 2019 reduction was Raytheon Company, cutting an estimated $543M.
- Citadel Advisors fully exited Celgene Corp in Q4 2019, selling an estimated $681M.
- Citadel Advisors's ten largest holdings make up 23% of its $230B portfolio in Q4 2019.
- Citadel Advisors opened 1,220 new positions and closed 1,266 in Q4 2019.
- Citadel Advisors's portfolio value rose 8.7% quarter-over-quarter to $230B.
Based on Citadel Advisors's 13F filing for Q4 2019, filed 14 Feb 2020.